101 – 150 of 150
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- « previous
- 1
- 2
- next »
- 2011
-
Mark
Myeloablative allogeneic stem cell transplantation for lymphoblastic lymphoma in Sweden: A retrospective study.
(
- Contribution to journal › Letter
-
Mark
Continuing high early death rate in acute promyelocytic leukemia: a population-based report from the Swedish Adult Acute Leukemia Registry
(
- Contribution to journal › Article
-
Mark
Long-term survival following allogeneic or syngeneic stem cell transplant for follicular lymphoma in Sweden.
(
- Contribution to journal › Article
-
Mark
Hematopoietic stem cell transplantation rates and long-term survival in acute myeloid and lymphoblastic leukemia: Real-World Population-Based Data From the Swedish Acute Leukemia Registry 1997-2006.
(
- Contribution to journal › Article
-
Mark
LPL is the strongest prognostic factor in a comparative analysis of RNA-based markers in early chronic lymphocytic leukemia
(
- Contribution to journal › Article
-
Mark
Array-based genomic screening at diagnosis and during follow-up in chronic lymphocytic leukemia
(
- Contribution to journal › Article
-
Mark
Results from a randomized trial of salvage chemotherapy followed by lestaurtinib for patients with FLT3 mutant AML in first relapse
(
- Contribution to journal › Article
- 2010
-
Mark
Population-based analyses in adult acute lymphoblastic leukemia
(
- Contribution to journal › Letter
-
Mark
Effective CD3 T-cell depletion using the CliniMacs (R) System to produce peripheral blood progenitor cell products for haploidentical transplantation in 23 children and adults: the updated Lund experience
2010) 36th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantat/9th Meeting of the EBMT Data-Management-Group/26th Meeting of the EBMT Nurses Group/2nd EBMT Qual Management Meeting In Bone Marrow Transplantation 45(Suppl.2). p.325-325(
- Contribution to journal › Published meeting abstract
-
Mark
Distinct gene expression profiles in subsets of chronic lymphocytic leukemia expressing stereotyped IGHV4-34 B-cell receptors
(
- Contribution to journal › Article
-
Mark
Superior long-term survival with a high rate of allogeneic stem cell transplantation in AML (non-APL) patients below 60 years of age
2010) 36th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantat/9th Meeting of the EBMT Data-Management-Group/26th Meeting of the EBMT Nurses Group/2nd EBMT Qual Management Meeting In Bone Marrow Transplantation 45. p.9-10(
- Contribution to journal › Published meeting abstract
-
Mark
Lack of association between the MDM2 promoter polymorphism SNP309 and clinical outcome in chronic lymphocytic leukemia
(
- Contribution to journal › Article
-
Mark
Verification that common variation at 2q37.1, 6p25.3, 11q24.1, 15q23, and 19q13.32 influences chronic lymphocytic leukaemia risk
(
- Contribution to journal › Article
-
Mark
High-density screening reveals a different spectrum of genomic aberrations in chronic lymphocytic leukemia patients with 'stereotyped' IGHV3-21 and IGHV4-34 B-cell receptors
(
- Contribution to journal › Article
-
Mark
Large but not small copy-number alterations correlate to high-risk genomic aberrations and survival in chronic lymphocytic leukemia: a high-resolution genomic screening of newly diagnosed patients.
(
- Contribution to journal › Article
-
Mark
Effect of pamidronate 30 mg versus 90 mg on physical function in patients with newly diagnosed multiple myeloma (Nordic Myeloma Study Group): a double-blind, randomised controlled trial
(
- Contribution to journal › Article
-
Mark
Melphalan and prednisone plus thalidomide or placebo in elderly patients with multiple myeloma
(
- Contribution to journal › Article
-
Mark
Common variants at 2q37.3, 8q24.21, 15q21.3 and 16q24.1 influence chronic lymphocytic leukemia risk
(
- Contribution to journal › Article
- 2009
-
Mark
Mechanisms of anti-cancer action and pharmacology of clofarabine
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry
(
- Contribution to journal › Article
-
Mark
High-dose iodine-131-metaiodobenzylguanidine with haploidentical stem cell transplantation and posttransplant immunotherapy in children with relapsed/refractory neuroblastoma.
(
- Contribution to journal › Article
-
Mark
Proportion of Adult AML Patient Population Receiving Allogeneic Stem Cell Transplantation and Long-Term Outcome: Real World Data From the Swedish National Acute Leukemia Registry.
(
- Contribution to journal › Published meeting abstract
-
Mark
LPL Is the Strongest Prognostic Factor in a Comparative Study of RNA-Based Markers in Chronic Lymphocytic Leukemia
(
- Contribution to journal › Published meeting abstract
-
Mark
Bendamustine versus chlorambucil in treatment- naive patients with chronic lymphocytic leukemia: Updated results of an international phase III study
2009) 14th Annual Meeting of the European-Hematology-Association In Haematologica-The Hematology Journal 94. p.0355-0355(
- Contribution to journal › Published meeting abstract
-
Mark
Large but not small copy-number alterations correlate to high-risk genomic aberrations and survival in chronic lymphocytic leukemia: A high-resolution genomic screening in newly diagnosed patients
2009) 14th Annual Meeting of the European-Hematology-Association In Haematologica-The Hematology Journal 94. p.0354-0354(
- Contribution to journal › Published meeting abstract
-
Mark
Bendamustine in the Treatment of Chronic Lymphocytic Leukemia - Consistent Superiority Over Chlorambucil in Elderly Patients and Across Clinically Defined Risk Groups
(
- Contribution to journal › Published meeting abstract
-
Mark
Phase III Randomized Study of Bendamustine Compared With Chlorambucil in Previously Untreated Patients With Chronic Lymphocytic Leukemia.
(
- Contribution to journal › Article
-
Mark
Results From a Randomized Trial of Salvage Chemotherapy Followed by Lestaurtinib for FLT3 Mutant AML Patients in First Relapse
(
- Contribution to journal › Published meeting abstract
- 2008
-
Mark
Normalization of Illumina Infinium whole-genome SNP data improves copy number estimates and allelic intensity ratios.
(
- Contribution to journal › Article
-
Mark
Cyclophosphamide plus dexamethasone is an efficient initial treatment before high-dose melphalan and autologous stem cell transplantation in patients with newly diagnosed multiple myeloma - Results of a randomized comparison with vincristine, doxorubicin, and dexamethasone
(
- Contribution to journal › Article
-
Mark
High Resolution Screening of Copy-Number Alterations in Chronic Lymphocytic Leukemia Using Affymetrix 250K SNP-Arrays Reveals a Higher Complexity of Genomic Alterations in Patients with Unmutated IGHV Genes
(
- Contribution to journal › Published meeting abstract
-
Mark
Segmentation-based detection of allelic imbalance and loss-of-heterozygosity in cancer cells using whole genome SNP arrays
(
- Contribution to journal › Article
-
Mark
Bendamustine Versus Chlorambucil as First-Line Treatment in B Cell Chronic Lymphocytic Leukemia: An Updated Analysis from An International Phase III Study
(
- Contribution to journal › Published meeting abstract
-
Mark
Screening For Copy-Number Alterations And Loss-Of-Heterozygosity In Chronic Lymphocytic Leukemia - A Comparative Study Of Four Differently Designed, High Resolution Microarray Platforms
2008) 13th Congress of the European-Hematology-Association In Haematologica-The Hematology Journal 93. p.0536-0536(
- Contribution to journal › Published meeting abstract
-
Mark
A Randomised Placebo Controlled Study With Melphalan/Prednisone Vs Melphalan/Prednisone/Thalidomide: Quality Of Life And Toxicity
2008) 13th Congress of the European-Hematology-Association In Haematologica-The Hematology Journal 93. p.0209-0209(
- Contribution to journal › Published meeting abstract
-
Mark
Screening for copy-number alterations and loss of heterozygosity in chronic lymphocytic leukemia-A comparative study of four differently designed, high resolution microarray platforms.
(
- Contribution to journal › Article
- 2007
-
Mark
Rapid and effective CD3 T-cell depletion with a magnetic cell sorting program to produce peripheral blood progenitor cell products for haploidentical transplantation in children and adults.
(
- Contribution to journal › Article
- 2006
-
Mark
Purine analogues: rationale for development, mechanisms of action, and pharmacokinetics in hairy cell leukemia.
(
- Contribution to journal › Article
-
Mark
Subcutaneous alemtuzumab vs ATG in adjusted conditioning for allogeneic transplantation: influence of Campath dose on lymphoid recovery, mixed chimerism and survival.
(
- Contribution to journal › Article
-
Mark
The pattern of deoxycytidine- and deoxyguanosine kinase activity in relation to messenger RNA expression in blood cells from untreated patients with B-cell chronic lymphocytic leukemia
(
- Contribution to journal › Article
-
Mark
Attitude towards remission induction for elderly patients with acute myeloid leukemia influences survival.
(
- Contribution to journal › Article
-
Mark
Impact of age on survival after intensive therapy for multiple myeloma: a population-based study by the Nordic Myeloma Study Group.
(
- Contribution to journal › Article
- 2005
-
Mark
Monitoring oral cyclosporine therapy
(
- Contribution to journal › Letter
-
Mark
Insamling av navelsträngsblod bör finansieras offentligt
(
- Contribution to journal › Letter
-
Mark
Distinct patterns of hematopoietic stem cell involvement in acute lymphoblastic leukemia.
(
- Contribution to journal › Article
-
Mark
Outcomes of reduced-intensity transplantation for chronic myeloid leukemia: an analysis of prognostic factors from the Chronic Leukemia Working Party of the EBMT
(
- Contribution to journal › Article
-
Mark
Outcomes for reduced-intensity allogeneic transplantation for multiple myeloma: an analysis of prognostic factors from the Chronic Leukaemia Working Party of the EBMT
(
- Contribution to journal › Article
- 2004
-
Mark
Identification of a commonly amplified 4.3 Mb region with overexpression of the C8FW gene, encoding a phosphoprotein regulated by mitogenic pathways, but not of the MYC gene in MYC-containing double minutes in myeloid malignancies.
(
- Contribution to journal › Article
- 2003
-
Mark
Increased remissions from one course for intermediate-dose cytosine arabinoside and idarubicin in elderly acute myeloid leukaemia when combined with cladribine. A randomized population-based phase II study
(
- Contribution to journal › Article
- 2002
-
Mark
RT-PCR analysis of acute myeloid leukemia with t(8;16)(p11;p13): Identification of a novel MOZ/CBP transcript and absence of CBP/MOZ expression.
(
- Contribution to journal › Letter
- « previous
- 1
- 2
- next »